MAPT and Alzheimer disease: A prominent pathological feature of AD brains is the accumulation of Aβ and NFTs composed of hyperphosphoryled tau (Grontvedt et al., 2018) and a growing body of evidence suggests that that Aβ and tau have synergistic effects in advancing AD-type neurodegeneration (Busche and Hyman, 2020).